<SEC-DOCUMENT>0001213900-26-057942-index.html : 20260515 <SEC-HEADER>0001213900-26-057942.hdr.sgml : 20260515 <ACCEPTANCE-DATETIME>20260515170916 ACCESSION NUMBER: 0001213900-26-057942 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20260515 FILED AS OF DATE: 20260515 DATE AS OF CHANGE: 20260515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XTL BIOPHARMACEUTICALS LTD CENTRAL INDEX KEY: 0001023549 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: L3 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36000 FILM NUMBER: 26989668 BUSINESS ADDRESS: STREET 1: XTL BIOPHARMACEUTICALS LTD STREET 2: C/O ALSTON & BIRD LLP, 90 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 972 9 955 7080 MAIL ADDRESS: STREET 1: 26 BEN-GURION ST. CITY: RAMAT GAN STATE: L3 ZIP: 5112001 </SEC-HEADER> <DOCUMENT> <TYPE>6-K <SEQUENCE>1 <FILENAME>ea0291180-6k_xtlbio.htm <DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER <TEXT> Document 1 - file: ea0291180-6k_xtlbio.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>ea029118001ex99-1.htm <DESCRIPTION>NOTICE AND PROXY STATEMENT WITH RESPECT TO THE COMPANY'S EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS <TEXT> Document 2 - file: ea029118001ex99-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>3 <FILENAME>ea029118001ex99-2.htm <DESCRIPTION>PROXY CARD FOR HOLDERS OF ORDINARY SHARES WITH RESPECT TO THE COMPANY'S EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS <TEXT> Document 3 - file: ea029118001ex99-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>ea029118001_ex99-1img.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: ea029118001_ex99-1img.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>ea029118001_ex99-2img.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: ea029118001_ex99-2img.jpg
</DOCUMENT> </SEC-DOCUMENT>